PeptideStack
5.2kquestions
20kanswers
220users

Does fatigue at week nine of a GLP-1 receptor agonist usually resolve without a dose change?

Asked 23 Jul 2024Modified 20 months agoViewed 28k times
6

The particulars: fatigue · nine · a GLP-1 receptor agonist.

I have read the obvious sources and they disagree with each other, so I would rather ask people who have actually done this.

I have a working setup and a notebook, and I am prepared to be told that my setup is inadequate if that is the answer.

Which parts of this are load-bearing and which parts are habit?

fatigue
fatigue

Tiredness on treatment: how much is energy deficit, how much is dehydration or electrolyte drift, how much is genuinely drug-attributable, and…

78 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
shareeditfollowflag
IB
askedilaria_bertone33k3823 Jul 2024
6Same experience, and it settled in about ten days at the same step. – tare_weight 3 months ago
add a comment

5 Answers

Accepted answer first, then by votes
84

Accepted answer

Week 9 is day 63: on a four-week ladder that is week 1 of dose step 3, and — at the seven-day half-life this class runs on — 9 half-lives in. Steady state is about five half-lives, so day 35 is where the concentration stops climbing on its own. Day 63 is 4 weeks past it, which means the level is no longer the variable. That distinction is most of the question: at week 1 of a step, an effect that is still accumulating is indistinguishable from one that is not resolving unless you know which side of day 35 you are on. Fatigue at any week has at least three candidate sources — the energy deficit, the fall in micronutrient intake that rides along with it, and the agent itself — and only the first two are cheaply measurable. Dose decisions are made under supervision, and nothing here is medical advice.

The relevant physiology is that a large deficit reduces both available substrate and spontaneous activity, and the second is often mistaken for the first.

A deficit beyond about a thousand kilocalories a day reliably produces fatigue, reduced training performance and reduced spontaneous movement. With appetite suppressed, deficits of that size arrive by accident rather than by plan.

To be exact about it, carbohydrate intake specifically affects training performance and perceived energy at a given total intake, which is why very low carbohydrate approaches feel worse in the gym at matched energy.

Ferritin as an acute-phase reactant is a recognised limitation and is why it is interpreted alongside an inflammatory marker.

Attributing a symptom with a wide differential to the most recent change is a common and expensive error.

Sleep is a variable here too, and no amount of eating fixes sleep debt.

shareimprove this answerflag
ID
answered · acceptedines_delacruz16k1620 Aug 2024
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
72

Answering this needs to know the size of the deficit, since fatigue tracks it closely and predictably.

Dehydration from reduced fluid intake alongside reduced food intake produces headache, lethargy and postural dizziness, and is the cheapest thing on the list to correct.

Concretely, sleep quality often changes during rapid weight loss in both directions, and sleep debt produces fatigue that no amount of dietary adjustment will fix.

Sleep restriction produces measurable decrements in subjective energy and in training performance independently of energy intake.

If it persists at an adequate intake, get bloods rather than more theories.

shareimprove this answerflag
VR
answeredv_ramaswamy68k5731 Aug 2024
3Adding a vote because this deserves more of them. – helena_vidmar 30 days ago
add a comment
35

If it persists at an adequate intake, it needs blood work rather than more speculation.

Three days of honest weighed intake usually settles this. Estimated intake in this situation is systematically wrong and usually wrong in the direction that hides the problem.

To be exact about it, fatigue that appeared abruptly, rather than gradually with the deficit, is a different pattern and points away from intake.

Nothing here is medical advice.

Abrupt onset points away from the deficit and towards something else.

edited 7 Sept 2024 by cal_hennessy — clarified the distinction between purity and content

shareimprove this answerflag
CH
answeredcal_hennessy17k279 Aug 2024
29

Start with the actual intake, because a substantially suppressed appetite produces deficits far larger than intended and fatigue is the first symptom.

Hypothyroidism, sleep apnoea, depression and anaemia all present as fatigue and all become more likely rather than less in this population, so attribution to the compound should be a diagnosis of exclusion.

Energy deficits above roughly a thousand kilocalories a day are associated with measurable reductions in resting metabolic rate, spontaneous activity and subjective energy in controlled studies.

Check fluid and sodium before anything more exotic.

shareimprove this answerflag
DF
answeredDr_Nadia_Farsi104k24729 Jul 2024
27

Answer first: fatigue in this context is usually an energy-intake problem before it is a drug effect, and the arithmetic is the first place to look.

Iron deficiency is common, particularly in menstruating women, and low intake plus a reduced red-meat share makes it more likely. Ferritin is the test, and it is an acute-phase reactant so it needs interpreting alongside CRP.

Self-reported intake underestimates measured intake by twenty per cent or more in doubly labelled water comparisons.

Weigh three days of intake honestly. That answers this most of the time.

shareimprove this answerflag
DA
answeredDr_Rosalind_Achebe69k14715 Nov 2024
5Same pattern here, and it resolved on the timeline described. – RP_C18 8 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.